Angel Yeast's true earnings power might be less than its statutory profit due to distortions from unusual items. Consideration of risks facing the company is crucial for a comprehensive understanding of its financial health.

Analysts show less optimism post-results due to reduced revenue forecasts and a slight dip in EPS expectations. The consensus price target for Angel Yeast fell significantly, indicating a lower future valuation.

Angel Yeast's lower P/E ratio is due to its poor earnings outlook. Shareholders accept this, acknowledging future earnings may not bring pleasant surprises. A significant share price rise seems unlikely under these conditions.

Angel Yeast is noted for an impressive ROE, successful profit utilization, and growth rate above industry average. Analyst data predicts a payout ratio of 30% and a ROE of 15% over the next three years.

While a decline in ROCE might be concerning, potential growth from reinvestment and increased sales could bode well for the stock long term. The stock's 73% return over five years suggests positive market sentiment.